| Study | Exclusion reasons | Remarks | Reference(s) | ||
|---|---|---|---|---|---|
| Vadrevu, 2021 | - | no control group |
Vadrevu KM et al. medrxiv;2021.12.28.21268468v1 10.1101/2021.12.28.21268468 |
||
| Greish, 2022 | prospective cohort | no control group | |||
| Liu, 2021 | randomized controlled trial | no clinically relevant endpoint |
Liu J J Infect Dis 2021 Dec 27;jiab627. 10.1093/infdis/jiab627 |
||
| Tawinprai, 2022 | prospective cohort | no clinically relevant endpoint |
Tawinprai K et al. medrxiv;2022.01.07.22268883v1 10.1101/2022.01.07.22268883 |
||
| Chen, 2021 | randomized controlled trial | other |
Chen J Zhonghua Liu Xing Bing Xue Za Zhi 2021 Dec 10;42(12):2077-2081. 10.3760/cma.j.cn112338-20210807-00617 |